A Method for Determining the Kinetics of Small-Molecule-Induced Ubiquitination

Area of Science:

• Biochemistry
• Molecular Biology
• Drug Discovery

Background:

• Targeted protein degradation utilizes the ubiquitin-proteasome system for disease treatment.
• Cereblon (CRBN)-dependent bifunctional degradation activating compounds (BiDACs) are key tools in this field.
• Understanding the catalytic rate of BiDACs is crucial for drug discovery.

Purpose of the Study:

• To develop an in vitro system for measuring the kinetics of target protein ubiquitination.
• To characterize the affinities involved in the BiDAC-CRBN-target protein interaction.
• To provide a tool for optimizing BiDAC properties.

Main Methods:

• Development of an in vitro system to measure protein ubiquitination kinetics.
• Application of an essential activator kinetic model to experimental data.
• Characterization of binding affinities in binary, ternary, and full ubiquitination complexes.

Main Results:

• Successfully established an in vitro system to quantify ubiquitination kinetics.
• Determined affinities between BiDACs, BRD4 bromodomain 1 (BD1), and CRBN.
• Provided kinetic and thermodynamic data for BiDAC-mediated degradation.

Conclusions:

• The developed in vitro system is a valuable tool for studying BiDACs.
• This work enhances understanding of the catalytic and thermodynamic properties of BiDACs.
• Facilitates optimization of BiDACs for targeted protein degradation drug discovery.